Healthcare's Mixed Bag: Resilience, Risks, and Recovery
Update: 2025-10-03
Description
Healthcare's rocky recovery: While innovation surges, supply chain woes linger and stocks lag behind the S&P 500. Is iRhythm a ticking time bomb with its cash burn and high valuation? Or will giants like AbbVie and UnitedHealth, with their massive revenue and strategic investments, continue to dominate despite market shake-ups? Investors beware: not all healthcare stocks are created equal.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel